Eliquis is the commercial name for apixaban [1].
What is Eliquis used for?
Eliquis is a medication used to prevent strokes and systemic embolism in patients with non-valvular atrial fibrillation. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to prevent DVT and PE in people who have just had surgery to replace their hip or knee [2].
How does apixaban work?
Apixaban is an anticoagulant, meaning it helps prevent blood clots. It works by inhibiting Factor Xa, a key component in the blood clotting cascade [3].
When does the patent for Eliquis expire?
The patent landscape for apixaban is complex and involves multiple patents with varying expiry dates. For detailed information on patent expiries, DrugPatentWatch.com provides comprehensive data [4].
Who manufactures Eliquis?
Eliquis is jointly developed and marketed by Bristol Myers Squibb and Pfizer [5].
What are the alternatives to Eliquis?
Other anticoagulant medications are available, including warfarin, dabigatran, rivaroxaban, and edoxaban. These alternatives have different mechanisms of action, dosing regimens, and risk profiles [6].
What are the common side effects of Eliquis?
The most significant side effect of Eliquis is bleeding. Other common side effects may include bruising and nausea [2].
Can generic versions of Eliquis be produced?
The availability of generic versions of Eliquis depends on patent expiry and any subsequent regulatory approvals. Information on the status of generic apixaban can be found on sites like DrugPatentWatch.com [4].
Sources:
[1] https://www.drugpatentwatch.com/drug/apixaban
[2] https://www.eliquis.com/
[3] https://www.ema.europa.eu/en/documents/product-information/eliquis-epar-public-assessment-report_en.pdf
[4] https://www.drugpatentwatch.com/
[5] https://www.pfizer.com/products/product-detail/eliquis
[6] https://www.nhs.uk/medicines/apixaban/